Skip to main content
Clinical Trials/ACTRN12605000379617
ACTRN12605000379617
Recruiting
Phase 4

A randomised trial of botulinum toxin injections into the submandibular and parotid glands to reduce drooling in children with neurological disorders

Murdoch Children's Research Institute0 sites56 target enrollmentSeptember 13, 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Excessive drooling in children with neurological disorders
Sponsor
Murdoch Children's Research Institute
Enrollment
56
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Problem with drooling Guardians able to understand study requirements and give informed consent.

Exclusion Criteria

  • Previous botulinum toxin therapy to salivary glandsPrevious saliva control surgeryAny BTX\-A treatment in previous 6 monthsNot fit enough to undergo general anaesthesiaUnwillingness to go off drooling medication for length of study.

Outcomes

Primary Outcomes

Not specified

Similar Trials